Rosalie E. Ferner
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications
Development and Initial Validation of the Quality of life Evaluation in NF2-related Schwannomatosis Trials (QUEST) Assessment.
Journal: medRxiv : the preprint server for health sciences
Published: June 29, 2026
Platform trial design for neurofibromatosis type 1, NF2-related schwannomatosis and non-NF2-related schwannomatosis: A potential model for rare diseases.
Journal: Neuro-oncology practice
Published: July 15, 2024
Association of sociodemographic and clinical factors with the quality of life of Brazilian individuals with Neurofibromatosis type 1: a cross-sectional study.
Journal: Anais brasileiros de dermatologia
Published: June 17, 2023
Cross-cultural adaptation and psychometric properties of the Brazilian Portuguese version of the Impact of Neurofibromatosis type 1 on Quality of Life (INF1-QoL) questionnaire.
Journal: The British journal of dermatology
Published: November 18, 2022
ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1.
Journal: EClinicalMedicine
Published: July 19, 2022
Management of neurofibromatosis type 1-associated plexiform neurofibromas.
Journal: Neuro-oncology
Published: June 03, 2022
ERN GENTURIS clinical practice guidelines for the diagnosis, treatment, management and surveillance of people with schwannomatosis.
Journal: European journal of human genetics : EJHG
Published: November 07, 2021
Neurovascular complications in adults with Neurofibromatosis type 1: A national referral center experience.
Journal: American journal of medical genetics. Part A
Published: October 01, 2021
Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: September 19, 2021
Location, symptoms, and management of plexiform neurofibromas in 127 children with neurofibromatosis 1, attending the National Complex Neurofibromatosis 1 service, 2018-2019.
Journal: American journal of medical genetics. Part A
Published: June 18, 2021
Lessons learned from drug trials in neurofibromatosis: A systematic review.
Journal: European journal of medical genetics
Published: March 29, 2021
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: October 21, 2020
Last Updated: 09/26/2026